AlphaFold predicted structure
DHODH · Q02127

Mean pLDDT
96.1/ 100
Very high
395 residues
Confidence breakdown
- Very high(≥ 90)91%
- Confident(70–90)8%
- Low(50–70)2%
- Very low(< 50)0%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
dihydroorotate dehydrogenase (quinone)
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Clefting
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalDeafness and congenital structural abnormalities
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalSkeletal dysplasia
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
+1 more panels — install the extension to see the full list inline on any page.
postaxial acrofacial dysostosis
rheumatoid arthritis
multiple sclerosis
psoriatic arthritis
relapsing-remitting multiple sclerosis
Arthritis
familial hyperlipidemia
COVID-19
coronary artery disorder
glioblastoma
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Dihydroorotate dehydrogenase (quinone), mitochondrial
Catalyzes the conversion of dihydroorotate to orotate with quinone as electron acceptor. Required for UMP biosynthesis via de novo pathway
DHODH · Q02127

Mean pLDDT
96.1/ 100
Very high
395 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0